TLR signaling is known to promote obesity-induced resistance to insulin and leptin [42, 43], suggesting that upregulation of Peli3 in response to HFD is implicated in the increased serum concentrations of insulin and leptin observed in the present study. The gene discussed is PELI3; the disease is obesity due to melanocortin 4 receptor deficiency.